A detailed history of Quantbot Technologies LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Quantbot Technologies LP holds 3,757 shares of LLY stock, worth $2.93 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,757
Previous 1,745 115.3%
Holding current value
$2.93 Million
Previous $1.58 Million 110.77%
% of portfolio
0.14%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $1.55 Million - $1.93 Million
2,012 Added 115.3%
3,757 $3.33 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $1.26 Million - $1.59 Million
1,745 New
1,745 $1.58 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $2.38 Million - $2.81 Million
-4,540 Reduced 51.16%
4,334 $2.53 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $269,948 - $372,165
621 Added 7.52%
8,874 $4.77 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $93,998 - $125,686
-268 Reduced 3.15%
8,253 $3.87 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $1.29 Million - $1.51 Million
4,146 Added 94.77%
8,521 $2.93 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $1.32 Million - $1.53 Million
4,094 Added 1456.94%
4,375 $1.6 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $282,248 - $321,652
-952 Reduced 77.21%
281 $90,000
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $1.36 Million - $1.59 Million
-4,873 Reduced 79.81%
1,233 $399,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $185,639 - $230,703
-791 Reduced 11.47%
6,106 $1.75 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $231,145 - $286,853
-1,028 Reduced 12.97%
6,897 $1.91 Million
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $1.76 Million - $2.16 Million
7,925 New
7,925 $1.83 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $4.38 Million - $5.8 Million
-33,571 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $4.91 Million - $5.68 Million
33,571 New
33,571 $4.97 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $2.99 Million - $3.71 Million
-28,003 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $1 Million - $1.09 Million
9,367 Added 50.26%
28,003 $3.13 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $2.06 Million - $2.41 Million
18,636 New
18,636 $2.06 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $7.74 Million - $8.67 Million
-73,089 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $5.42 Million - $6.78 Million
63,161 Added 636.19%
73,089 $7.84 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $1.38 Million - $1.58 Million
-18,207 Reduced 64.71%
9,928 $847,000
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $784,548 - $926,107
-10,572 Reduced 27.31%
28,135 $2.18 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $3.17 Million - $3.4 Million
38,707
38,707 $3.27 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.